The ELCC 2024 programme is now online!
The European Lung Cancer Congress 2024 will provide insights into the prevention, diagnosis, biology and multi-disciplinary management of thoracic malignancies. Specifically, the Congress will include educational and scientific sessions covering:
- Prevention, screening and early diagnosis of thoracic tumours;
- Recent developments on molecular diagnosis and therapeutic classes for lung cancer;
- New challenges and opportunities with immuno and targeted therapies;
- The evolving role of multimodality and multidisciplinary decisions in lung cancer;
- State of the art for NSCLC, SCLC, mesothelioma and mediastinal tumours.
Learning objectives
- Learn about novel treatment modalities for early-stage lung cancer
- Update for the optimal use of immunotherapy to treat patients with lung cancer
- Learn how to best sequence or combine multimodal therapies in common and rare thoracic tumours
- Update on novel and targeted therapies to treat patients with lung cancer.
- Review the emerging contribution of precision medicine, liquid biopsies, omics and AI technologies for the optimal management of thoracic tumours.
Accreditation
ESMO-MORA: The Congress programme has been accredited with 21 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details
Disclaimer
All Speakers and Discussants are required to declare their interests, if any, and include a Declaration of Interest (DOI) slide at the start of their presentation(s).
The experts invited by the ELCC organisers as Discussants are selected on an individual basis to provide their own interpretation of the data and are not acting as ESMO spokespersons.
The ESMO recommendations on the clinical utility of new drugs are only presented in the ESMO Clinical Practice Guidelines and such recommendations represent the only official position of ESMO.